摘要
【目的】探讨半乳糖凝集素-3(Galectin-3)在乳腺良、恶性病变组织中的表达及其与淋巴转移的关系。【方法】采用免疫组织化学E1iVision法检测139例乳腺良、恶性病变组织中Galectin-3的表达情况,比较有、无淋巴结转移乳腺癌组织中Galectin-3的表达。【结果】Galeetin-3在乳腺恶性病变组织中阳性表达率(91.4%)明显高于良性病变(33.33%),差异有显著性(P〈0.01);伴有淋巴结转移乳腺癌组织的阳性表达率(97.83%)高于不伴有淋巴转移(81.82%)乳腺癌组织,差异有显著性(P〈0.05);而且有淋巴结转移的Galectin-3阳性表达多呈中、强阳性,Galectin-3表达与淋巴结转移呈正相关(rs=0.521,P〈0.05)。【结论】Galectin-3在乳腺恶性病变中的表达明显高于良性病变中的表达,随着肿瘤的侵袭、淋巴转移,其表达强度逐渐增强。其对预测乳腺癌的发展及而后判断有泰者价值.
[Objective] To explore the expression of Galectin-3 in benign and malignant breast tissue and its relation-ship with lymphatic metastasis. [Methods]The expression of Galectin-3 in the tissues of 139 benign and malignant breast lesion was detected by immunochemical EliVision method. The expression of Galectin-3 between breast cancer with or without lymphatic metastasis was compared. [Results] The positive expression rate of Galectin-3 in breast cancer tissue (91.4%) was obviously higher than that in benign breast tissue(33. 3%), and there was statistical significance( P〈0. 0001). The expression of Galectin-3 in breast cancer with lymphatic metastasis was also higher than that without lymphatic metastasis (97.83 % vs 81.82 %), and there was statistical significance( P〈0. 05). And the expression of Galectin-3 in the patients with lymphatic metastasis was moderately or grossly positive. High expression of Galectin-3 was positively eorrelated with lymphatic metastasis(rs= 0. 521, P G0.05). [Conclusion] The expression of Galectin-3 in malig-nant breast tissue is obviously higher than that in benign breast tissue. The expression of Galectin-3 gradually increases with the invasion and lymphatic metastasis of tumor. It is valuable for predicting the progress and prognosis of breast cancer.
出处
《医学临床研究》
CAS
2010年第7期1205-1207,共3页
Journal of Clinical Research
基金
2009年深圳市科技计划项目(编号:200903202)